PRF Technologies Ltd. (PRFX)
PRFX trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$0.8180
-4.88% on the day
Market cap
$2.9M
Nano cap
Revenue · 2025
$17K
Prior year not contiguous
Net income · 2025
-$5.0M
-29541.2% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | PRFX on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | Israel |
| IPO year | 2020 |
| SEC CIK | 0001801834 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | L3 |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $17K |
| Net income | -$5.0M |
| Operating income | -$5.1M |
| Net margin | -29541.2% |
| Operating margin | -30129.4% |
| Revenue growth | No prior-year revenue to compare |
| Cash | $3.1M |
| Total assets | $12.0M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 168.4× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | POS AM | 2026-09-03 |
| Latest annual report | 20-F | 2026-03-26 |
| Latest quarterly / interim | 6-K | 2026-09-28 |
Source: SEC EDGAR submissions feed, 259 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| MBIO | Mustang Bio Inc. | $0.3768 | -8.63% | $2.9M |
| HCWB | HCW Biologics Inc. | $1.26 | -14.87% | $2.8M |
| ONCO | Onconetix Inc. | $0.5550 | -6.00% | $2.9M |
| KAPA | Kairos Pharma Ltd. | $0.8287 | -0.40% | $2.8M |
| DCOY | Decoy Therapeutics Inc. | $1.24 | -13.29% | $3.0M |
| XRTX | XORTX Therapeutics Inc. Common Shares | $1.68 | -2.33% | $3.1M |
| GOVX | GeoVax Labs Inc. | $0.2656 | -5.92% | $2.7M |
| APVO | Aptevo Therapeutics Inc. | $1.73 | -5.79% | $3.1M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier